Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-278.19M
↓ 137% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-117.58M
Historical baseline
PeriodValueYoY Change
TTM$-278.19M-45.0%
2024$-191.90M-38.0%
2023$-139.03M-33.4%
2022$-104.20M-57.7%
2021$-66.08M-44.8%
2020$-45.64M+8.1%
2019$-49.67M+31.6%
2018$-72.60M+30.2%
2017$-104.02M+16.4%
2016$-124.44M-